Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Pen vs Syringe Preference in RA
NCT01793259Phase 3Completed
- Sponsor
- medac GmbH
- Start
- Jul 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in rheumatoid arthritis (RA), sponsored by medac GmbH. Started Jul 2012; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01793259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01793259.